D. Connolly

发表

G. Lip, G. Bhatia, Russell C Davis, 2005, Expert review of cardiovascular therapy.

Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)

Deepak L. Bhatt, S. Yusuf, J. Bosch, 2020, Circulation.

Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report.

M. Petch, P. Dardas, A. Kenny, 1994, The Journal of heart valve disease.

The additive prognostic value of coronary calcium score (CCS) to single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI)-real world data from a single center

P. Kirchhof, C. Varma, A. Notghi, 2019, Journal of Nuclear Cardiology.

Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions

G. Lip, B. Chin, D. Connolly, 2002, BMJ : British Medical Journal.

Statin prescription is essential in peripheral vascular disease.

J. Leyon, S. Babu, D. Connolly, 2010, Journal of vascular and interventional radiology : JVIR.

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

P. Kirchhof, R. Schnabel, T. Zeller, 2022, Journal of the American Heart Association.

Abstract 15100: Reduction in Total Cardiovascular Events With the PCSK9 Inhibitor Evolocumab in Patients With Cardiovascular Disease in the FOURIER Trial

A. Keech, R. Giugliano, M. Sabatine, 2017 .

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Khalid Yusoff, Frederick M. Costello, Martin O'Donnell, 2017, Lancet.

Statins and rheumatoid arthritis

G. Bhatia, Russell C Davis, M. Sosin, 2004, The Lancet.

Exercise-induced coronary artery dissection in a 54-year-old male without atherosclerosis: A case report

D. Connolly, V. Grey, A. D'Sa, 2016 .

Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry.

R. D. Jenkins, A. Capucci, G. Lip, 2020, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

infective endocarditis A randomized trial of aspirin on the risk of embolic events in patients with

G. Lip, A. Choudhury, Russell C Davis, 2012 .

Re: 'Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin'.

A. Choudhury, D. Connolly, S. Chowdhury, 2005, Age and ageing.

Phaeochromocytoma presenting acutely as severe cardiac failure.

D. Connolly, D. A. Mariathas, 1994, Journal of accident & emergency medicine.

Pushing the envelope too far?

G. Lip, D. Connolly, T. Lo, 2004, Journal of the American College of Cardiology.

Massive diltiazem overdose.

D. Connolly, M. Bastow, M. Nettleton, 1993, The American journal of cardiology.

Horner's syndrome occurring as a complication of pleurectomy.

D. Connolly, 1991, Thorax.

Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care

S. Al Saif, D. Connolly, D. Connolly, 2021, Expert review of cardiovascular therapy.

Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus

G. Lip, G. Dimitropoulos, D. Connolly, 2017, Expert opinion on pharmacotherapy.

The EXCEL Trial: The Interventionalists' Perspective

C. Varma, Vinoda Sharma, D. Connolly, 2021, European cardiology.

Drug-eluting stents: a comprehensive appraisal.

G. Lip, M. Butt, D. Connolly, 2009, Future cardiology.

Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial.

A. Keech, R. Giugliano, M. Sabatine, 2019, JAMA cardiology.

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study.

J. Ferrières, D. Nanchen, M. Arca, 2023, The Lancet regional health. Europe.

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

P. Kirchhof, D. Kavanagh, N. Kalia, 2021, European Heart Journal.

Combination lipid-lowering therapy as first-line strategy in very high-risk patients.

M. Banach, J. Kastelein, U. Laufs, 2021, European heart journal.

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

M. Eriksson, U. Laufs, J. Ferrières, 2021, Atherosclerosis plus.

Smartphone and wearable detected atrial arrhythmias in Older Adults: Results of a fully digital European Case finding study

U. Schotten, R. Schnabel, S. Winkelmann, 2022, European heart journal. Digital health.

Single right coronary artery with congenital absence of left coronary system

G. Lip, D. Connolly, Subramanya G N Upadhyaya, 2018, BMJ Case Reports.

High‐risk myocardial infarction patients appear to derive more mortality benefit from short door‐to‐balloon time than low‐risk patients

G. Lip, C. Varma, T. Millane, 2009, International journal of clinical practice.

Identification of right atrial thrombi using transoesophageal echocardiography.

P. Dardas, A. Kenny, D. Connolly, 1995, European heart journal.